NCT06703437View on ClinicalTrials.gov

Long Acting Neuraxial Peri-prostatic Block in Cancer

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 13, 2022

Primary Completion Date

February 23, 2023

Study Completion Date

June 1, 2026

Conditions
Prostate Cancer
Interventions
DRUG

Dehydrated alcohol

Long-acting neuraxial blockade at the time of prostate biopsy by periprostatic injection of Dehydrated alcohol.

DRUG

Lidocaine IV

By periprostatic injection, 2mL

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER